JP6297333B2 - カルコンまたはジヒドロカルコンのモノテルペン誘導体および脱色素剤としてのそれらの使用 - Google Patents
カルコンまたはジヒドロカルコンのモノテルペン誘導体および脱色素剤としてのそれらの使用 Download PDFInfo
- Publication number
- JP6297333B2 JP6297333B2 JP2013549797A JP2013549797A JP6297333B2 JP 6297333 B2 JP6297333 B2 JP 6297333B2 JP 2013549797 A JP2013549797 A JP 2013549797A JP 2013549797 A JP2013549797 A JP 2013549797A JP 6297333 B2 JP6297333 B2 JP 6297333B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- cosmetic
- formula
- extract
- bristles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007854 depigmenting agent Substances 0.000 title claims description 5
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 title description 9
- 235000005513 chalcones Nutrition 0.000 title description 9
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 title description 2
- 150000002773 monoterpene derivatives Chemical class 0.000 title description 2
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 claims description 48
- 239000000284 extract Substances 0.000 claims description 42
- 239000002537 cosmetic Substances 0.000 claims description 38
- 241000608894 Helichrysum Species 0.000 claims description 11
- 239000004480 active ingredient Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 230000035614 depigmentation Effects 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 206010064127 Solar lentigo Diseases 0.000 claims description 2
- 230000003796 beauty Effects 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 208000031066 hyperpigmentation of the skin Diseases 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims 3
- 238000004061 bleaching Methods 0.000 claims 1
- GHISAUFWVUOBIR-UHFFFAOYSA-N 3-phenyl-1-[2,4,6-trihydroxy-3-(3-methyl-6-propan-2-ylcyclohex-2-en-1-yl)phenyl]propan-1-one Chemical compound CC(C)C1CCC(C)=CC1C1=C(O)C=C(O)C(C(=O)CCC=2C=CC=CC=2)=C1O GHISAUFWVUOBIR-UHFFFAOYSA-N 0.000 description 32
- 241000196324 Embryophyta Species 0.000 description 19
- 210000003491 skin Anatomy 0.000 description 18
- 230000000694 effects Effects 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 241000604893 Lindera umbellata Species 0.000 description 10
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- 108060008724 Tyrosinase Proteins 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 241000131322 Helichrysum gymnocephalum Species 0.000 description 9
- 102000003425 Tyrosinase Human genes 0.000 description 9
- 239000000419 plant extract Substances 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 8
- 238000000605 extraction Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 208000012641 Pigmentation disease Diseases 0.000 description 6
- 235000016761 Piper aduncum Nutrition 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- 241001131629 Lancea Species 0.000 description 4
- 241000606344 Mitrella <gastropod> Species 0.000 description 4
- 244000160860 Mitrella kentii Species 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- 244000302909 Piper aduncum Species 0.000 description 4
- 241000671744 Piper hostmannianum Species 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229930003935 flavonoid Natural products 0.000 description 4
- 235000017173 flavonoids Nutrition 0.000 description 4
- 150000002215 flavonoids Chemical class 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000008099 melanin synthesis Effects 0.000 description 4
- 210000002752 melanocyte Anatomy 0.000 description 4
- 230000019612 pigmentation Effects 0.000 description 4
- LOYXTWZXLWHMBX-VOTSOKGWSA-N pinocembrin chalcone Chemical compound OC1=CC(O)=CC(O)=C1C(=O)\C=C\C1=CC=CC=C1 LOYXTWZXLWHMBX-VOTSOKGWSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000037307 sensitive skin Effects 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 241001182316 Linda Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 244000309464 bull Species 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 229930003949 flavanone Natural products 0.000 description 3
- 150000002208 flavanones Chemical class 0.000 description 3
- 235000011981 flavanones Nutrition 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 3
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 2
- JEPSZTLDPWGHPQ-UHFFFAOYSA-N 1-Phenyl-3-(2,4,6-trihydroxyphenyl)-2-propen-1-one Natural products OC1=CC(O)=CC(O)=C1C=CC(=O)C1=CC=CC=C1 JEPSZTLDPWGHPQ-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- ACRWYXSKEHUQDB-UHFFFAOYSA-N 3-phenylpropionitrile Chemical compound N#CCCC1=CC=CC=C1 ACRWYXSKEHUQDB-UHFFFAOYSA-N 0.000 description 2
- CVKXAEQFTCAGJZ-UHFFFAOYSA-N 5,7-dihydroxy-6,8-bis(3-methyl-6-propan-2-ylcyclohex-2-en-1-yl)-2-phenyl-2,3-dihydrochromen-4-one Chemical compound CC(C)C1CCC(C)=CC1C1=C(O)C(C2C(CCC(C)=C2)C(C)C)=C(OC(CC2=O)C=3C=CC=CC=3)C2=C1O CVKXAEQFTCAGJZ-UHFFFAOYSA-N 0.000 description 2
- 241000669761 Aggregata Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 0 CIC1=C(*)C(C=O)=C(*)CC1* Chemical compound CIC1=C(*)C(C=O)=C(*)CC1* 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000546273 Lindera <angiosperm> Species 0.000 description 2
- AFJBDWHCOLAFQN-UHFFFAOYSA-N Linderachalcone Natural products CC(C)C1CCC(C)=CC1C1=C(O)C=C(O)C(C(=O)C=CC=2C=CC=CC=2)=C1O AFJBDWHCOLAFQN-UHFFFAOYSA-N 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- FGUBFGWYEYFGRK-HNNXBMFYSA-N Pinocembrin Natural products Cc1cc(C)c2C(=O)C[C@H](Oc2c1)c3ccccc3 FGUBFGWYEYFGRK-HNNXBMFYSA-N 0.000 description 2
- 241000722363 Piper Species 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 240000006806 Piper hispidum Species 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- 241000758706 Piperaceae Species 0.000 description 2
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 2
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 2
- 229940088601 alpha-terpineol Drugs 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 150000001789 chalcones Chemical class 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- NXMUXTAGFPJGTQ-UHFFFAOYSA-N decanoic acid;octanoic acid Chemical compound CCCCCCCC(O)=O.CCCCCCCCCC(O)=O NXMUXTAGFPJGTQ-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000003810 hyperpigmentation Effects 0.000 description 2
- 208000000069 hyperpigmentation Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
- 229960004705 kojic acid Drugs 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 230000003061 melanogenesis Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- URFCJEUYXNAHFI-CYBMUJFWSA-N (2r)-5,7-dihydroxy-2-phenyl-2,3-dihydrochromen-4-one Chemical compound C1([C@H]2CC(=O)C3=C(O)C=C(C=C3O2)O)=CC=CC=C1 URFCJEUYXNAHFI-CYBMUJFWSA-N 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 1
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 description 1
- GVSPXQVUXHMUMA-MDWZMJQESA-N (e)-3-(3,5-ditert-butyl-4-hydroxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one Chemical compound C1=CC(OC)=CC=C1C(=O)\C=C\C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 GVSPXQVUXHMUMA-MDWZMJQESA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- SERQFHAVLYPAHE-UHFFFAOYSA-N 1-phenyl-3-(2,3,4-trihydroxyphenyl)prop-2-en-1-one Chemical class OC1=C(O)C(O)=CC=C1C=CC(=O)C1=CC=CC=C1 SERQFHAVLYPAHE-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 1
- PQSXNIMHIHYFEE-UHFFFAOYSA-N 4-(1-phenylethyl)benzene-1,3-diol Chemical compound C=1C=C(O)C=C(O)C=1C(C)C1=CC=CC=C1 PQSXNIMHIHYFEE-UHFFFAOYSA-N 0.000 description 1
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 1
- KTVKIASZLSYKIA-UHFFFAOYSA-N 5,7-dihydroxy-6-(3-methyl-6-propan-2-ylcyclohex-2-en-1-yl)-2-phenyl-2,3-dihydrochromen-4-one Chemical compound CC(C)C1CCC(C)=CC1C1=C(O)C=C(OC(CC2=O)C=3C=CC=CC=3)C2=C1O KTVKIASZLSYKIA-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241001081440 Annonaceae Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 1
- 101000935015 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) N-acetyl-6-hydroxytryptophan oxidase ivoB Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000035890 Helichrysum arenarium Species 0.000 description 1
- 241000131379 Helichrysum cordifolium Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100031413 L-dopachrome tautomerase Human genes 0.000 description 1
- 101710093778 L-dopachrome tautomerase Proteins 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- AHSGBCHOIWPPDO-UHFFFAOYSA-N Methyllinderatone Natural products COc1cc(O)c2C(=O)CC(Oc2c1C3C=C(C)CCC3C(C)C)c4ccccc4 AHSGBCHOIWPPDO-UHFFFAOYSA-N 0.000 description 1
- 206010028400 Mutagenic effect Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 101710173694 Short transient receptor potential channel 2 Proteins 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical group CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000001203 anti-plasmodial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000001130 astrocyte Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- UIFJOXOHICDFDO-UHFFFAOYSA-N benzene-1,3,5-triol Chemical compound OC1=CC(O)=CC(O)=C1.OC1=CC(O)=CC(O)=C1 UIFJOXOHICDFDO-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000008436 biogenesis Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229960003993 chlorphenesin Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 229940073499 decyl glucoside Drugs 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- LGKJJUMVDIOTCE-UHFFFAOYSA-N linderatone Natural products CC(C)C1CCC(C)=CC1C1=C(O)C=C(O)C2=C1OC(C=1C=CC=CC=1)CC2=O LGKJJUMVDIOTCE-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 231100000243 mutagenic effect Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000009979 protective mechanism Effects 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940075554 sorbate Drugs 0.000 description 1
- 229950003429 sorbitan palmitate Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000000547 structure data Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 150000003611 tocopherol derivatives Chemical class 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000028973 vesicle-mediated transport Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 150000003785 γ-tocopherols Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
- C07C49/835—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups having unsaturation outside an aromatic ring
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
・コルドンキージョ(Piper aduncum)ii、葉、コショウ科(Piperaceae):(−)−メチル−リンデラチン、
・Piper hostmannianum var. Berbicenseiii、葉(コショウ科):(−)−メチル−リンデラチン
・Lindera umbellata var. membranaceaiv、vおよびlanceavi、葉viiまたは樹皮viii、クスノキ科:(+)−リンデラチン、リンデラカルコンix、メチル−リンデラチン
・Mitrella kentii、幹の樹皮、バンレイシ科(Annonaceae):(−)−リンデラチンx
から単離されている。
・溶媒を完全に蒸発させることによって直接蒸発乾固させて、最終抽出物を得ることができる。
・その使用目的に適合するならば、抽出溶媒中で液体として保存することができる。この場合、ろ液を、蒸発工程工程によって多少濃縮することができる。
・濃縮することができる。目的の組成物を得るこの濃縮工程工程は、2つの非混和性溶媒間の液/液抽出、シリカ、イオン交換樹脂などの担体上への吸収などの当業者に公知の技術によって実施することができる。
・ジムノカルコン(式VI)(式中、
・炎症を誘発するストレスによる色素沈着斑過剰などの色素沈着斑、例えばUVで誘発される褐色がかった色素沈着斑の軽減および/もしくは除去、または肝斑の軽減および/もしくは除去;
・色素沈着の原因であるメラニンの産生の軽減および/または阻害
のために有利である。
・任意により、ゲル化した水性または含水アルコール溶液、
・任意により、二相のローションタイプの分散液、
・水中油もしくは油中水または多重エマルジョン、
・水性ゲル
の形態で提供することができ、美容液、クリーム、ゲル、軟膏、乳液、ローション、ペーストまたはフォームとして提供することができる。さらに、例えばスティックの形態を包含するエアロゾルまたは固体として適用することもできる。
5kgの乾燥した地上部を還流下、35Lおよび25Lの95%エタノールで2回抽出した。合わせたろ液を濃縮し、乾燥した。褐色ペーストの形態で得られた抽出物は、100gの固体あたり0.28gのジムノカルコンを含んでいた。
参考文献xv,xviで開示される下記反応スキームにしたがった2段階合成によって、リンデラチンを得た。
地上部を乾燥し、粉砕した後、酢酸エチルで抽出した。そのような抽出物をヘプタン、ジクロロメタンおよびアセトンで溶出させた中圧シリカカラム上で分画し、その結果、TLC分析および同一画分を組み合わせた後に11の画分を得た。活性画分8を次いでC−18グラフト化シリカ上アセトニトリル/水+0.1%酢酸の勾配で分画し、その結果、式VIのジムノカルコンが単離された(0.02%収率/乾燥植物)。
陽イオンモードでのエレクトロスプレーソース質量分析法による分析によって、付加物[M+Na]+=431.3および[2M+Na]+=839.4を得た。陰イオンモードで、[M−H]−=407.3が見出された。組成物の質量は、したがって408g/molであった。MS/MSで、α−テルピネオール(またはp−メント−1−エン−8−オール)に対応する152フラグメントが放出された。
葉を乾燥し、粉砕した後、室温で15時間暗所での浸漬によってエタノール96(1wt/l0vol)で抽出した。この抽出物(17%収率)をヘプタン、酢酸エチルおよびメタノールで溶出させた中圧シリカカラム上で分画し、その結果、TLC分析および同一画分を組み合わせた後に21の画分を得た。画分3および4をその後アセトニトリル/水の勾配でC−18グラフト化シリカ上、分取HPLCによって分画し、その結果、式Vのメチルリンデラチンが単離された(13%収率/抽出物、2.2%/乾燥植物)。
実施例1:脱色素美容液
組成物 量
リンデラチン 0.1g
EDTA(二)ナトリウム 0.05〜0.5g
セテアリールアルコール/セテアレス33 1〜10g
カプリリル(ジ)エーテル 1〜10g
ステアリン酸グリセリル 1〜8g
(シクロペンタ)デカメチルシロキサン 1〜10g
カプリン酸カプリル酸/トリグリセリド30 70 1〜10g
グリコール酸 1〜5g
水酸化ナトリウム 1〜3g
安息香酸 適量
精製水 100gにする量
組成物 量
ヘリクリサム・ジムノセファラムの乾燥抽出物 0.5g
カルボマーK 0.2〜2g
精製クロルフェネシン 0.05〜1g
フェノキシエタノール 適量
セチルアルコール 0.1〜2g
パルミチン酸ソルビタン 1〜8g
(ポリ)ソルベート40 0.1〜2g
カプリン酸カプリル酸/トリグリセリド30 70 1〜10g
(p)メトキシケイヒ酸エチルヘキシル 1〜10g
(アルファ)酢酸トコフェリル 0.5g
(トリ)エタノールアミン 0.8g
MBBT/デシルグルコシド混合物 1〜10g
精製水 100gにする量
メラノサイトは星状細胞であり、表皮の基底層中に少量含まれている。それらの主な機能はメラニン形成を確実にすることであり、メラニン形成とは、メラニンがメラノソームとして知られる特殊化した細胞小器官に合成されるプロセスであり、次いで隣接するケラチノサイトへとそれらの樹状伸長部を通して輸送され、分配される。このケラチノサイトとの接触は、紫外線の変異原性効果に対する表皮の保護機序である皮膚色素沈着を可能にする。各メラノサイトは約36のケラチノサイトに関連し、結果として「表皮−メラニン単位」を形成する。
ii Orjala J. et al. New monoterpene-substituted dihydrochalcones from Piper aduncum. Helv. Chem. Acta 1993, 76, 1481-1488
iii Portet B. et al., Activity-guided isolation of antiplasmodial dihydrochalcones and flavanones from Piper hostmannianum var. berbicense. Phytochemistry 2007, 68, 1312-1320
iv Ichino K. et al., Revised structures of Linderatone and methyllinderatone. Heterocycles 1990, 31, 549-553.
v Ichino K. et al., Studies on the flavonoid components of Lindera umbellata THUNB. Var. membranacea (maxim.) momiyama Chem Pharm Bull 1989 37, 944-947
vi Ichino K. et al., A new flavanone, neolinderatone, from Lindera umbellata thunb. Var. Lancea momiyama. Chem Pharm Bull 1989, 37, 1426-1427
vii Ichino K.et al., Two novel flavonoids from the leaves of Lindera umbellata var. Lancea and L. umbellata. Tetrahedron 1988, 44, 3251-3260
viii Shimomura H. et al., A chalcone derivative from the bark of Lindera umbellata. Phytochemistry 1988, 27, 3937-3939
ix Ichino K., Two flavonoids from two Lindera umbellata varieties. Phytochemistry 1989, 28, 955-956
x Benosman A. et al., New terpenylated dihydrochalcone derivatives isolated from Mitrella kentii. J. Nat. Prod.1997, 60, 921-924.
xiJimbow,K. et al. Intracellular vesicular trafficking of tyrosinase gene family protein in eu- and pheomelanosome biogenesis. Pigment Cell Res. 2000. ;13 Suppl 8. :110. -7. 13 Suppl 8, 110-117.
xii Curto,E.V. et al. Inhibitors of mammalian melanocyte tyrosinase: in vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors. Biochem. Pharmacol. 1999, 57, 663-672.
xiii Kuwabara,Y. et al. Topical Application of gamma-Tocopherol Derivative Prevents UV-Induced Skin Pigmentation. Biol. Pharm. Bull. 2006. Jun. ;29. (6. ):1175. -9. 29, 1175-1179
xiv Ortonne, J. P. and Bissett, D. L. (2008) J.Investig.Dermatol.Symp.Proc.2008.Apr;13(1):10-4. 13, 10-14
xv Kamarul, A. M et al. Tetrahedron 59 (2003), 6113
xvi Crombie L, et al. J. Chem. Soc. Perkin Trans. 1988, 1251
Claims (13)
- 皮膚および/または剛毛および/または毛髪を脱色および/または薄い色にするための、請求項1に記載の使用。
- 皮膚上の加齢によるシミを軽減および/または除去するための、請求項1に記載の使用。
- UVによって誘発される褐色がかった色素沈着斑または肝斑を軽減および/または除去するための、請求項1に記載の使用。
- 薬剤として使用するための請求項5に記載の化粧品または皮膚科学的組成物。
- 皮膚および/または剛毛および/または毛髪の脱色素のために使用するための請求項5に記載の皮膚科学的組成物。
- 皮膚の色素沈着過剰の治療で使用するための請求項5に記載の皮膚科学的組成物。
- 皮膚上の色素沈着斑を軽減および/または除去および/または予防するための請求項5に記載の化粧品組成物の使用。
- 皮膚および/または剛毛および/または毛髪を脱色および/または薄い色にするための、請求項5に記載の化粧品組成物の使用。
- 皮膚および/または剛毛および/または毛髪を脱色および/または薄い色にするための美容方法であって、皮膚および/または剛毛および/または毛髪に請求項5で定義される化粧品組成物を塗布することを含んでなる、方法。
- 皮膚上の色素沈着斑を軽減および/または除去および/または予防するための美容方法であって、皮膚に請求項5で定義される化粧品組成物を塗布することを含んでなる、方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1150386A FR2970416B1 (fr) | 2011-01-18 | 2011-01-18 | Nouveaux derives monoterpeniques de chalcone ou dihydrochalcone et leur utilisation comme depigmentants |
FR1150386 | 2011-01-18 | ||
PCT/EP2012/050669 WO2012098134A1 (en) | 2011-01-18 | 2012-01-18 | Monoterpene derivatives of chalcone or dihydrochalcone and their use as depigmenting agents |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014508137A JP2014508137A (ja) | 2014-04-03 |
JP6297333B2 true JP6297333B2 (ja) | 2018-03-20 |
Family
ID=44310851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013549797A Active JP6297333B2 (ja) | 2011-01-18 | 2012-01-18 | カルコンまたはジヒドロカルコンのモノテルペン誘導体および脱色素剤としてのそれらの使用 |
Country Status (22)
Country | Link |
---|---|
US (1) | US9629786B2 (ja) |
EP (1) | EP2665484B1 (ja) |
JP (1) | JP6297333B2 (ja) |
KR (1) | KR101916977B1 (ja) |
CN (1) | CN103313722B (ja) |
AR (1) | AR084874A1 (ja) |
AU (1) | AU2012208626B2 (ja) |
BR (1) | BR112013018287A2 (ja) |
CA (1) | CA2823629C (ja) |
ES (1) | ES2653148T3 (ja) |
FR (1) | FR2970416B1 (ja) |
HK (1) | HK1185267A1 (ja) |
IL (1) | IL227447A (ja) |
MA (1) | MA34840B1 (ja) |
MX (1) | MX360027B (ja) |
PL (1) | PL2665484T3 (ja) |
PT (1) | PT2665484T (ja) |
RU (1) | RU2595860C2 (ja) |
TN (1) | TN2013000283A1 (ja) |
TW (1) | TWI582069B (ja) |
WO (1) | WO2012098134A1 (ja) |
ZA (1) | ZA201305458B (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6017259B2 (ja) * | 2012-10-12 | 2016-10-26 | 花王株式会社 | エンドセリン作用抑制剤 |
DE102013204070A1 (de) * | 2013-03-11 | 2014-09-11 | Beiersdorf Ag | Verwendung kosmetisch oder dermatologisch unbedenklicher substituierter Michael-Akzeptoren zur Verhinderung, Verminderung oder Prophylaxe der Tyrosinaseaktivität der menschlichen Haut und/oder deren Aufhellung |
CN103553894B (zh) * | 2013-11-05 | 2016-01-06 | 辽宁石油化工大学 | 一种1,3-二苯基-1-丙酮的合成方法 |
WO2018178041A1 (en) * | 2017-03-30 | 2018-10-04 | F. Hoffmann-La Roche Ag | Novel pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection |
FR3074421B1 (fr) | 2017-12-01 | 2020-07-17 | Pierre Fabre Dermo-Cosmetique | Extrait d'helichrysum gymnocephalum pour le traitement et/ou la prevention des dermatoses inflammatoires |
KR102408169B1 (ko) * | 2020-08-28 | 2022-06-14 | 주식회사 포스코 | 오카닌을 함유하는 항노화 또는 피부재생용 조성물 |
FR3123568B1 (fr) | 2021-06-03 | 2023-06-09 | Laboratoires M&L | Utilisation cosmetique d’un extrait huileux de dreches d'immortelle comme agent eclaircissant de la peau |
FR3142089A1 (fr) | 2022-11-18 | 2024-05-24 | Laboratoires M&L | Utilisation cosmétique d’un extrait d'immortelle comme agent éclaircissant de la peau |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3150841B2 (ja) * | 1994-04-06 | 2001-03-26 | ポーラ化成工業株式会社 | 皮膚外用剤 |
JP3650147B2 (ja) * | 1994-06-27 | 2005-05-18 | ポーラ化成工業株式会社 | メラニン生成阻害剤及び皮膚外用剤 |
JPH0812566A (ja) * | 1994-06-29 | 1996-01-16 | Shiseido Co Ltd | チロシナーゼ活性阻害剤 |
JP3993936B2 (ja) * | 1998-05-22 | 2007-10-17 | 一丸ファルコス株式会社 | メラニン生成抑制剤及び化粧料組成物 |
PL1748767T3 (pl) * | 2004-05-28 | 2012-08-31 | Unigen Inc | 1-(3-metylo-2,4-dimetoksyfenylo)-3-(2',4'-dihydroksyfenylo)-propan jako silny inhibitor tyrozynazy |
JP2006124322A (ja) * | 2004-10-28 | 2006-05-18 | Takasago Internatl Corp | ヒアルロニダーゼ阻害剤、および該ヒアルロニダーゼ阻害剤を含有する皮膚外用組成物および口腔用組成物 |
FR2884250B1 (fr) * | 2005-04-06 | 2010-01-08 | Coletica | Utilisation des aurones pour leur activite depigmentante ou inhibitrice de la melanogenese dans des compositions cosmetiques ou dermatologiques |
FR2903014B1 (fr) * | 2006-06-30 | 2008-09-26 | Occitane L | Composition cosmetique a base d'acide gras polyinsatures et ses utilisations |
JP2008156325A (ja) * | 2006-12-26 | 2008-07-10 | Shiseido Co Ltd | 皮膚外用剤および美白剤 |
JP2010100554A (ja) * | 2008-10-23 | 2010-05-06 | B & C Laboratories Inc | メラニン生成抑制剤 |
JP2010159220A (ja) * | 2009-01-07 | 2010-07-22 | Kao Corp | ドーパオキシダーゼ活性抑制剤および細胞増殖活性促進剤 |
US20110159125A1 (en) * | 2009-12-29 | 2011-06-30 | Avon Products, Inc. | CGRP Compositions and Uses Thereof |
-
2011
- 2011-01-18 FR FR1150386A patent/FR2970416B1/fr active Active
-
2012
- 2012-01-17 AR ARP120100153A patent/AR084874A1/es not_active Application Discontinuation
- 2012-01-17 TW TW101101715A patent/TWI582069B/zh not_active IP Right Cessation
- 2012-01-18 PT PT127004836T patent/PT2665484T/pt unknown
- 2012-01-18 KR KR1020137021570A patent/KR101916977B1/ko active IP Right Grant
- 2012-01-18 CA CA2823629A patent/CA2823629C/en not_active Expired - Fee Related
- 2012-01-18 US US13/823,681 patent/US9629786B2/en active Active
- 2012-01-18 ES ES12700483.6T patent/ES2653148T3/es active Active
- 2012-01-18 JP JP2013549797A patent/JP6297333B2/ja active Active
- 2012-01-18 CN CN201280004986.9A patent/CN103313722B/zh active Active
- 2012-01-18 RU RU2013135683/15A patent/RU2595860C2/ru active
- 2012-01-18 AU AU2012208626A patent/AU2012208626B2/en not_active Ceased
- 2012-01-18 PL PL12700483T patent/PL2665484T3/pl unknown
- 2012-01-18 EP EP12700483.6A patent/EP2665484B1/en active Active
- 2012-01-18 WO PCT/EP2012/050669 patent/WO2012098134A1/en active Application Filing
- 2012-01-18 MA MA36134A patent/MA34840B1/fr unknown
- 2012-01-18 BR BR112013018287A patent/BR112013018287A2/pt not_active IP Right Cessation
- 2012-01-18 MX MX2013008133A patent/MX360027B/es active IP Right Grant
-
2013
- 2013-07-02 TN TNP2013000283A patent/TN2013000283A1/fr unknown
- 2013-07-11 IL IL227447A patent/IL227447A/en active IP Right Grant
- 2013-07-19 ZA ZA2013/05458A patent/ZA201305458B/en unknown
- 2013-11-13 HK HK13112687.8A patent/HK1185267A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
JP2014508137A (ja) | 2014-04-03 |
IL227447A (en) | 2017-10-31 |
ZA201305458B (en) | 2015-01-28 |
CN103313722B (zh) | 2016-04-27 |
WO2012098134A1 (en) | 2012-07-26 |
RU2595860C2 (ru) | 2016-08-27 |
AU2012208626B2 (en) | 2017-03-30 |
MX360027B (es) | 2018-10-18 |
TW201309637A (zh) | 2013-03-01 |
FR2970416B1 (fr) | 2013-02-22 |
AR084874A1 (es) | 2013-07-10 |
MX2013008133A (es) | 2013-09-13 |
NZ613331A (en) | 2015-08-28 |
PL2665484T3 (pl) | 2018-04-30 |
TWI582069B (zh) | 2017-05-11 |
RU2013135683A (ru) | 2015-02-27 |
KR101916977B1 (ko) | 2018-11-08 |
CA2823629A1 (en) | 2012-07-26 |
CN103313722A (zh) | 2013-09-18 |
KR20140012059A (ko) | 2014-01-29 |
BR112013018287A2 (pt) | 2016-11-16 |
CA2823629C (en) | 2021-07-06 |
MA34840B1 (fr) | 2014-01-02 |
US20130177515A1 (en) | 2013-07-11 |
EP2665484B1 (en) | 2017-11-01 |
IL227447A0 (en) | 2013-09-30 |
PT2665484T (pt) | 2018-02-05 |
ES2653148T3 (es) | 2018-02-06 |
HK1185267A1 (zh) | 2014-02-14 |
FR2970416A1 (fr) | 2012-07-20 |
EP2665484A1 (en) | 2013-11-27 |
TN2013000283A1 (en) | 2015-01-20 |
US9629786B2 (en) | 2017-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6297333B2 (ja) | カルコンまたはジヒドロカルコンのモノテルペン誘導体および脱色素剤としてのそれらの使用 | |
AU2012208626A1 (en) | Monoterpene derivatives of chalcone or dihydrochalcone and their use as depigmenting agents | |
JP5596251B2 (ja) | 皮膚化粧料及び頭髪化粧料 | |
JP5224648B2 (ja) | 抗皮膚炎症剤、美白剤及び抗皮膚老化剤 | |
WO2008147022A1 (en) | Anti-wrinkle composition for external applications to the skin containing biflavonoid derivatives | |
JP2011105666A (ja) | ドーパオキシダーゼ活性抑制剤及び美白剤 | |
JP4992164B2 (ja) | 化粧料組成物 | |
WO2016110276A1 (zh) | 含有黄柏酮的局部组合物及用其美白皮肤的方法 | |
JP2011032173A (ja) | チロシナーゼ阻害剤 | |
KR102000550B1 (ko) | 신갈나무 화분으로부터 분리된 폴리아민계 화합물을 함유하는 미백용 조성물 | |
JP2006316029A (ja) | エンドセリン−1産生抑制剤及びメラニン産生抑制剤 | |
KR101481884B1 (ko) | 코보페놀 a를 유효성분으로 포함하는 피부 미백용 조성물 | |
JP4319417B2 (ja) | メラニン産生不全症治療剤 | |
CN105106266A (zh) | 一种香芸火绒草提取物及其应用 | |
KR101191992B1 (ko) | 강활 추출물 또는 비사볼란겔론 화합물을 유효성분으로 포함하는 피부 미백용 조성물 | |
KR101887957B1 (ko) | 에피메디움 속 식물에서 추출된 에피메딘을 함유하는 조성물 | |
CN109952286A (zh) | 基于石斛属成分的皮肤保护组合物 | |
JP2005247736A (ja) | メラニン産生促進剤 | |
NZ613331B2 (en) | Monoterpene derivatives of chalcone or dihydrochalcone and their use as depigmenting agents | |
KR101208115B1 (ko) | 사티바논, 메디카르핀, 달베르긴, 이소리퀴리티제닌, 또는 이들의 약학적으로 허용가능한 염을 포함하는 피부 노화 억제 또는 피부 주름 개선용 조성물 | |
KR20010057776A (ko) | 피부미백제 | |
JP2010111645A (ja) | 美白剤及び皮膚化粧料 | |
KR20200006515A (ko) | 초피나무 추출물 또는 그 분획물을 유효성분으로 함유하는 항염, 주름개선, 미백용 화장료 조성물 및 그 제조방법 | |
JP2012092138A (ja) | 皮膚化粧料及び頭髪化粧料 | |
KR20200006292A (ko) | 초피나무 추출물 또는 그 분획물을 유효성분으로 함유하는 항염, 주름개선, 미백용 화장료 조성물 및 그 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20141121 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20150709 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150825 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151113 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20160506 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160831 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20161019 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20161222 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171127 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180221 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6297333 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |